Opining on the privacy policy issues, the minister said that instead of a unilateral approach such policy changes should have been made after wider consultation.
China approved a COVID-19 vaccine developed by an affiliate of state-backed pharmaceutical giant Sinopharm on Thursday, its first approved shot for general public use.